マーケットレポート詳細
臨床化学分析装置の世界市場：製品タイプ別、検査別2028年予測
Clinical Chemistry Analyzers Market by Product (Fully-automated and PoC Analyzers, Reagents), Test Type (Basic Metabolic, Liver, Renal, Lipid, Thyroid Function), End User (Hospitals, Clinics, Laboratories, Research) & Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年7月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文185ページになります。
- 商品コード：MAM3327
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
臨床化学分析装置の世界市場規模は2023年で130億ドル、2028年に165億ドル、市場の平均年成長率は4.9%になる見込みです。
レポートは臨床化学分析装置の世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、検査タイプ別市場、等）を中心に構成されています。また競合状況、主要企業情報（10社）、プライシング分析、業界構造分析などの分析も加味し、臨床化学分析装置市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆臨床化学分析装置の世界市場予測2021-2028年
・市場規模(US$)
◆製品別、市場-2028年
試薬
アナライザー（測定器）
・半自動アナライザー
・全自動アナライザー
・ポイントオブケアアナライザー
その他製品
※(市場規模US$)
◆検査タイプ別、市場-2028年
・基礎代謝パネル（BMP）
・肝パネル
・腎プロファイル
・脂質プロファイル
・甲状腺機能パネル
・電解質パネル
・特殊化学検査
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院/クリニック
・診断ラボラトリ
・研究ラボラトリ/研究機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン、ロシア
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
中南米
中東アフリカ
※国地域別に全セグメントの細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・プライシング分析
・特許分析
・バリューチェーン分析
・サプライチェーン分析
・エコシステムマッピング
・業界構造分析
・PESTLE分析
・貿易分析
・競合状況
・市場シェア分析
◆臨床化学分析装置の主要企業プロフィール動向
・F HOFFMANN-LA ROCHE LTD
・DANAHER CORPORATION
・ABBOTT LABORATORIES
・シーメンスヘルスケア株式会社
・THERMO FISHER SCIENTIFIC INC
・株式会社堀場製作所
・シスメックス株式会社
・EKF DIAGNOSTICS
・QUIDELORTHO CORPORATION
・株式会社 日立製作所
その他企業
・MINDRAY MEDICAL INTERNATIONAL LTD
・ELITECH GROUP
・BIOBASE GROUP
・SFRI
・TRIVITRON HEALTHCARE PVT LTD
・RANDOX LABORATORIES LTD
・MEDICA CORPORATION
・MERIL LIFE SCIENCES PVT LTD
・ERBA MANNHEIM
・GENRUI BIOTECH CO, LTD
・DIRUI
・TECO DIAGNOSTICS
・BALIO DIAGNOSTICS
・SNIBE CO LTD
・AMS ALLIANCE
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.2.2 MARKETS COVERED 26
・ FIGURE 1 CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENTATION
1.2.3 GEOGRAPHIC SCOPE 26
1.2.4 YEARS CONSIDERED 27
1.3 CURRENCY
1.4 LIMITATIONS 27
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT 28
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
・ FIGURE 2 CLINICAL CHEMISTRY ANALYZERS MARKET: RESEARCH DESIGN METHODOLOGY
2.2.1 SECONDARY DATA
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY DATA
2.2.2.1 PRIMARY SOURCES
2.2.2.2 KEY DATA FROM PRIMARY SOURCES
2.2.2.3 KEY INDUSTRY INSIGHTS
2.2.2.4 BREAKDOWN OF PRIMARY INTERVIEWS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND DEMAND-SIDE PARTICIPANTS
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.3.1.2 APPROACH 2: PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS
2.3.1.3 GROWTH FORECAST
2.3.1.4 CAGR PROJECTIONS
・ FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3.2 TOP-DOWN APPROACH 37
・ FIGURE 7 CLINICAL CHEMISTRY ANALYZERS MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
・ FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RISK ASSESSMENT
・ TABLE 1 CLINICAL CHEMISTRY ANALYZERS MARKET: RISK ASSESSMENT
2.8 LIMITATIONS 40
2.9 CLINICAL CHEMISTRY ANALYZERS MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY ANALYZER TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 CLINICAL CHEMISTRY ANALYZERS MARKET OVERVIEW
・ FIGURE 14 RISING ADOPTION OF POC PRODUCTS TO SUPPORT MARKET GROWTH DURING FORECAST PERIOD
4.2 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2023 VS. 2028
・ FIGURE 15 REAGENTS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2023 VS. 2028
・ FIGURE 16 BASIC METABOLIC PANEL SEGMENT TO HOLD LARGEST SHARE DURING FORECAST PERIOD
4.4 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2023 VS. 2028
・ FIGURE 17 HOSPITALS & CLINICS SEGMENT TO CONTINUE TO DOMINATE MARKET DURING FORECAST PERIOD
4.5 CLINICAL CHEMISTRY ANALYZERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 18 ASIA PACIFIC MARKET EXPECTED TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 CLINICAL CHEMISTRY ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF CHRONIC & LIFESTYLE DISEASES
・ TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS OR ABOVE, BY REGION (2022–2050)
5.2.1.2 GROWING ADOPTION OF POINT-OF-CARE TESTING DEVICES
5.2.1.3 INCREASING DEMAND FOR LABORATORY AUTOMATION
5.2.2 RESTRAINTS
5.2.2.1 REQUIREMENT FOR HIGH CAPITAL INVESTMENTS AND SHORTAGE OF SKILLED LABORATORY TECHNICIANS
5.2.2.2 AVAILABILITY OF REFURBISHED ANALYZERS
5.2.3 OPPORTUNITIES
5.2.3.1 INCREASING GOVERNMENT INITIATIVES AND FUNDING FOR PREVENTIVE CARE 53
5.2.3.2 GROWTH OPPORTUNITIES IN EMERGING ECONOMIES
5.2.4 CHALLENGES
5.2.4.1 INCREASING REGULATORY REQUIREMENTS
5.2.4.2 HIGH DEGREE OF CONSOLIDATION
5.3 PRICING ANALYSIS
・ TABLE 3 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
5.4 PATENT ANALYSIS
・ FIGURE 20 PATENT ANALYSIS FOR CLINICAL CHEMISTRY ANALYZERS (JANUARY 2013–DECEMBER 2022)
5.5 VALUE CHAIN ANALYSIS
・ FIGURE 21 VALUE CHAIN ANALYSIS OF CLINICAL CHEMISTRY ANALYZERS MARKET
5.6 SUPPLY CHAIN ANALYSIS
・ FIGURE 22 CLINICAL CHEMISTRY ANALYZERS MARKET: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM ANALYSIS
・ FIGURE 23 CLINICAL CHEMISTRY ANALYZERS MARKET: ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 4 CLINICAL CHEMISTRY ANALYZERS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 BARGAINING POWER OF BUYERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 PESTLE ANALYSIS
5.10 REGULATORY ANALYSIS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 CANADA
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 CHINA
5.10.3.2 JAPAN
5.10.3.3 INDIA
5.10.4 LATIN AMERICA
5.10.4.1 BRAZIL
5.10.4.2 MEXICO
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
・ TABLE 5 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
・ TABLE 6 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2018–2022 (USD MILLION)
6 CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 7 CLINICAL CHEMISTRY REAGENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 REAGENTS
6.2.1 RECURRENT PURCHASE REQUIREMENT OF REAGENTS TO DRIVE MARKET
・ TABLE 8 KEY PRODUCTS IN CLINICAL CHEMISTRY ANALYZERS REAGENTS MARKET
・ TABLE 9 CLINICAL CHEMISTRY REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 ANALYZERS 69
・ TABLE 10 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 11 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.1 SEMI-AUTOMATIC ANALYZERS
6.3.1.1 COST-EFFECTIVENESS OF SEMI-AUTOMATIC ANALYZERS TO PROPEL SEGMENT GROWTH
・ TABLE 12 KEY PRODUCTS IN SEMI-AUTOMATIC CLINICAL CHEMISTRY ANALYZERS MARKET
・ TABLE 13 SEMI-AUTOMATIC ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 FULLY AUTOMATIC ANALYZERS
6.3.2.1 RAPID SAMPLE PROCESSING AND REDUCTION OF TURNAROUND TIMES TO BOOST MARKET
・ TABLE 14 KEY PRODUCTS IN FULLY AUTOMATIC CLINICAL CHEMISTRY ANALYZERS MARKET
・ TABLE 15 FULLY AUTOMATIC ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 POINT-OF-CARE ANALYZERS
6.3.3.1 INCREASING ADOPTION OF POC TECHNOLOGIES TO DRIVE SEGMENT GROWTH
・ TABLE 16 KEY PRODUCTS IN POINT-OF-CARE CLINICAL CHEMISTRY ANALYZERS MARKET
・ TABLE 17 POINT-OF-CARE ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 OTHER PRODUCTS
・ TABLE 18 CLINICAL CHEMISTRY ANALYZERS FOR OTHER PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE
7.1 INTRODUCTION
・ TABLE 19 CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
7.2 BASIC METABOLIC PANEL
7.2.1 RISING INCIDENCE OF DIABETES AND OTHER CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 20 CLINICAL CHEMISTRY BASIC METABOLIC PANEL TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 LIVER PANEL 77
7.3.1 INCREASE IN LIVER-RELATED DISEASES TO DRIVE MARKET
・ TABLE 21 CLINICAL CHEMISTRY LIVER PANEL TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 RENAL PROFILE
7.4.1 RISING INCIDENCE OF ESRD PATIENTS TO PROPEL GROWTH OF RENAL PROFILE TESTING MARKET
・ TABLE 22 CLINICAL CHEMISTRY RENAL PROFILE TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 LIPID PROFILE
7.5.1 RAPID RISE IN OBESITY RATES TO PROPEL MARKET GROWTH
・ TABLE 23 CLINICAL CHEMISTRY LIPID PROFILE TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.6 THYROID FUNCTION PANEL
7.6.1 SPIKE IN INCIDENCE OF THYROID-RELATED DISORDERS TO DRIVE MARKET
・ TABLE 24 CLINICAL CHEMISTRY THYROID FUNCTION PANEL TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.7 ELECTROLYTE PANEL
7.7.1 INCREASING PREVALENCE OF HYPERTENSION AND KIDNEY DISEASES TO DRIVE GROWTH
・ TABLE 25 CLINICAL CHEMISTRY ELECTROLYTE PANEL TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.8 SPECIALTY CHEMICAL TESTS
7.8.1 SPECIALTY CHEMICAL TESTS SEGMENT TO GROW AT LOWEST CAGR DURING FORECAST PERIOD
・ TABLE 26 CLINICAL CHEMISTRY SPECIALTY CHEMICAL TESTS MARKET, BY REGION, 2021–2028 (USD MILLION)
8 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 27 CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS & CLINICS
8.2.1 INCREASE IN DISEASES & DISORDERS TO PROPEL MARKET GROWTH
・ TABLE 28 CLINICAL CHEMISTRY ANALYZERS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2021–2028 (USD MILLION)
8.3 DIAGNOSTIC LABORATORIES
8.3.1 RISE IN OUTSOURCING ACTIVITIES TO DIAGNOSTIC LABORATORIES AT REDUCED COSTS TO DRIVE MARKET 85
・ TABLE 29 CLINICAL CHEMISTRY ANALYZERS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021–2028 (USD MILLION)
8.4 RESEARCH LABORATORIES & INSTITUTES
8.4.1 GROWTH IN FUNDING FOR LIFE SCIENCE RESEARCH TO BOOST MARKET
・ TABLE 30 CLINICAL CHEMISTRY ANALYZERS MARKET FOR RESEARCH LABORATORIES & INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
8.5 OTHER END USERS
・ TABLE 31 CLINICAL CHEMISTRY ANALYZERS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 32 CLINICAL CHEMISTRY ANALYZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 24 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
・ TABLE 33 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 34 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 35 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 36 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 37 NORTH AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 INCREASING CASES OF DIABETES & OBESITY-RELATED DISEASES TO BOOST MARKET
・ TABLE 38 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 39 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 40 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 41 US: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 SPIKE IN PREVALENCE OF CHRONIC & LIFESTYLE DISEASES TO DRIVE MARKET GROWTH IN CANADA
・ TABLE 42 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 43 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 44 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 45 CANADA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
・ TABLE 46 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 47 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 48 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 49 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 50 EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN GERMANY 99
・ TABLE 51 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 52 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 53 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 54 GERMANY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 GROWING NUMBER OF ACCREDITED CLINICAL LABORATORIES TO PROPEL MARKET GROWTH
・ TABLE 55 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 56 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 57 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 58 UK: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 RISING R&D EXPENDITURE IN FRANCE TO BOOST MARKET
・ TABLE 59 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 60 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 61 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 62 FRANCE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 AGE-RELATED CHRONIC CONDITIONS OWING TO LARGE GERIATRIC POPULATION TO DRIVE MARKET GROWTH
・ TABLE 63 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 64 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 65 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 66 ITALY: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 INCREASING PREVALENCE OF AGE-ASSOCIATED DISORDERS TO DRIVE MARKET GROWTH
・ TABLE 67 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 68 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 69 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 70 SPAIN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.6 RUSSIA
9.3.6.1 INCREASING ACCESS TO QUALITY HEALTHCARE TO SUPPORT MARKET GROWTH IN RUSSIA
・ TABLE 71 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 72 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 73 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 74 RUSSIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.7 REST OF EUROPE
・ TABLE 75 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 76 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 77 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 78 REST OF EUROPE: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
・ FIGURE 25 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET SNAPSHOT
・ TABLE 79 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 80 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 81 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 82 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 83 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 CHINA
9.4.1.1 INCREASING AWARENESS OF PREVENTIVE CARE TO DRIVE DEMAND FOR CLINICAL CHEMISTRY ANALYZERS
・ TABLE 84 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 85 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 86 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 87 CHINA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 FAVORABLE REGULATORY FRAMEWORK TO DRIVE MARKET GROWTH IN JAPAN
・ TABLE 88 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 89 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 90 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 91 JAPAN: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 INCREASING PRIVATE & PUBLIC INVESTMENTS TO PROPEL MARKET GROWTH 120
・ TABLE 92 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 93 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 94 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 95 INDIA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
・ TABLE 96 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 97 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 98 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 99 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 LATIN AMERICA
・ TABLE 100 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 101 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 102 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION)
・ TABLE 103 LATIN AMERICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
・ TABLE 104 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 105 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 106 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY TEST TYPE, 2021–2028 (USD MILLION) 129
・ TABLE 107 MIDDLE EAST & AFRICA: CLINICAL CHEMISTRY ANALYZERS MARKET, BY END USER, 2021–2028 (USD MILLION) 129
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
10.2.1 RIGHT-TO-WIN APPROACHES ADOPTED BY PLAYERS
・ TABLE 108 CLINICAL CHEMISTRY ANALYZERS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 132
・ FIGURE 26 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN CLINICAL CHEMISTRY MARKET (2022)
10.4 MARKET SHARE ANALYSIS
・ FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS (2022)
・ TABLE 109 CLINICAL CHEMISTRY ANALYZERS MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION QUADRANT
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
・ FIGURE 28 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPANY EVALUATION MATRIX, 2022
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS (2022)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS 135
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES 135
・ FIGURE 29 CLINICAL CHEMISTRY ANALYZERS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS, 2022
10.7 COMPETITIVE SCENARIO
10.7.1 PRODUCT LAUNCHES & APPROVALS
・ TABLE 110 KEY PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
・ TABLE 111 KEY DEALS
10.7.3 OTHER DEVELOPMENTS
・ TABLE 112 KEY OTHER DEVELOPMENTS
11 COMPANY PROFILES
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, PRODUCT LAUNCHES, MNM VIEW, KEY STRENGTHS, STRATEGIC CHOICES, AND WEAKNESSES & COMPETITIVE THREATS)*
11.1.1 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 113 F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 30 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2022)
11.1.2 DANAHER CORPORATION
・ TABLE 114 DANAHER CORPORATION: BUSINESS OVERVIEW
・ FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2022)
11.1.3 ABBOTT LABORATORIES
・ TABLE 115 ABBOTT LABORATORIES: BUSINESS OVERVIEW
・ FIGURE 32 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
11.1.4 SIEMENS HEALTHCARE GMBH
・ TABLE 116 SIEMENS HEALTHCARE GMBH: BUSINESS OVERVIEW
・ FIGURE 33 SIEMENS HEALTHCARE GMBH: COMPANY SNAPSHOT (2022)
11.1.5 THERMO FISHER SCIENTIFIC INC.
・ TABLE 117 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
・ FIGURE 34 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
11.1.6 HORIBA, LTD.
・ TABLE 118 HORIBA, LTD.: BUSINESS OVERVIEW
・ FIGURE 35 HORIBA, LTD.: COMPANY SNAPSHOT (2022)
11.1.7 SYSMEX CORPORATION
・ TABLE 119 SYSMEX CORPORATION: BUSINESS OVERVIEW
・ FIGURE 36 SYSMEX CORPORATION: COMPANY SNAPSHOT (2022)
11.1.8 EKF DIAGNOSTICS 163
・ TABLE 120 EKF DIAGNOSTICS: BUSINESS OVERVIEW
・ FIGURE 37 EKF DIAGNOSTICS: COMPANY SNAPSHOT (2022)
11.1.9 QUIDELORTHO CORPORATION
・ TABLE 121 QUIDELORTHO CORPORATION: BUSINESS OVERVIEW
・ FIGURE 38 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT (2022)
11.1.10 HITACHI LTD.
・ TABLE 122 HITACHI LTD.: BUSINESS OVERVIEW
・ FIGURE 39 HITACHI LTD.: COMPANY SNAPSHOT (2022)
11.2 OTHER PLAYERS
11.2.1 MINDRAY MEDICAL INTERNATIONAL LTD.
11.2.2 ELITECH GROUP
11.2.3 BIOBASE GROUP
11.2.4 SFRI
11.2.5 TRIVITRON HEALTHCARE PVT. LTD.
11.2.6 RANDOX LABORATORIES LTD.
11.2.7 MEDICA CORPORATION
11.2.8 MERIL LIFE SCIENCES PVT. LTD.
11.2.9 ERBA MANNHEIM
11.2.10 GENRUI BIOTECH CO., LTD.
11.2.11 DIRUI
11.2.12 TECO DIAGNOSTICS
11.2.13 BALIO DIAGNOSTICS
11.2.14 SNIBE CO. LTD.
11.2.15 AMS ALLIANCE
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, PRODUCT LAUNCHES, MNM VIEW, KEY STRENGTHS, STRATEGIC CHOICES, AND WEAKNESSES & COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.